COMPOSITIONAL DIFFERENCES IN COMMERCIALLY AVAILABLE RECOMBINANT FACTOR VIIA PREPARATIONS AND THEIR ACTIVITY IN A PROTHROMBIN SYSTEM

被引：0
|
作者：
Kahn, Daniel [1 ]
Sadeghi, Nasiredin [1 ]
Hoppensteadt, Debra [1 ]
Fareed, Jawed [1 ]
机构：
[1] Loyola Univ Med Ctr, Maywood, IL USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2014年 / 89卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
51
引用
收藏
页码：E24 / E25
页数：2
相关论文
共 50 条
  • [21] Trends in Recombinant Factor VIIa Usage Before and After Introduction of Prothrombin Complex Concentrate
    Vossoughi, S.
    Schwartz, J.
    Stotler, B.
    [J]. TRANSFUSION, 2016, 56 : 250A - 251A
  • [22] Possible synergy between recombinant factor VIIa and prothrombin complex concentrate in hemophilia therapy
    Key, NS
    Christie, B
    Henderson, N
    Nelsestuen, GL
    [J]. THROMBOSIS AND HAEMOSTASIS, 2002, 88 (01) : 60 - 65
  • [23] Activated prothrombin complex concentrate for acquired haemophilia when recombinant factor VIIa fails
    Hussein, Z.
    Kudva, G. C.
    Reimers, H. J.
    [J]. HAEMOPHILIA, 2009, 15 (03) : 831 - 832
  • [24] A comparative analysis of heterogeneity in commercially available recombinant factor VIII products
    Baunsgaard, D.
    Nielsen, A. D.
    Nielsen, P. F.
    Henriksen, A.
    Kristensen, A. K.
    Bagger, H. W.
    Ezban, M.
    [J]. HAEMOPHILIA, 2018, 24 (06) : 880 - 887
  • [25] Protocolized warfarin reversal with 4-factor prothrombin complex concentrate versus 3-factor prothrombin complex concentrate with recombinant factor VIIa
    Barton, Cassie A.
    Hom, Marissa
    Johnson, Nathan B.
    Case, Jon
    Ran, Ran
    Schreiber, Martin
    [J]. AMERICAN JOURNAL OF SURGERY, 2018, 215 (05): : 775 - 779
  • [26] Dabigatran and its reversal with recombinant factor VIIa and prothrombin complex concentrate: A Sonoclot in vitro study
    Solbeck, Sacha
    Nilsson, Caroline U.
    Engstrom, Martin
    Ostrowski, Sisse R.
    Johansson, Par I.
    [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2014, 74 (07): : 591 - 598
  • [27] Evaluation of the bactericidal activity of povidone-iodine and commercially available gargle preparations
    Shiraishi, T
    Nakagawa, Y
    [J]. DERMATOLOGY, 2002, 204 : 37 - 41
  • [28] Effects of recombinant factor VIIa on platelet function and clot structure in blood with deficient prothrombin conversion
    Carr, ME
    Martin, EJ
    Kuhn, JG
    Seremetis, SV
    [J]. THROMBOSIS AND HAEMOSTASIS, 2003, 89 (05) : 803 - 811
  • [29] Pseudoprolongation of the Prothrombin Time During Treatment with Recombinant Factor VIIa for Bleeding in a Patient with a Spontaneous Factor VIII Inhibitor
    Marcus E. Carr
    Jan G. Kuhn
    Erika J. Martin
    Ann R. Tidwell
    Maura K. Hagane
    [J]. International Journal of Hematology, 2003, 77 : 308 - 309
  • [30] Pseudoprolongation of the prothrombin time during treatment with recombinant factor VIIa for bleeding in a patient with a spontaneous factor VIII inhibitor
    Carr, ME
    Kuhn, JG
    Martin, EJ
    Tidwell, AR
    Hagan, MK
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2003, 77 (03) : 308 - 309
12345